Stock Updates

Today’s Top Gainers in the Market Sanofi (NYSE:SNY) from Healthcare

Today’s top gainers include the company Sanofi (NYSE:SNY) which is in the industry Drug Manufacturers – Major, gaining -0.62% today. In the last week its performance is -1.22%, and -0.68% for the past quarter. Currently, Sanofi, SNY has a target price of 51.33, so today’s gain of -0.62% is a significant step towards its target price. The GAP today is therefore -1.01%.

Sanofi (NYSE:SNY), has a market cap of 102082.01, and is based in France. Insider ownership is at 16.40%, and institutional ownership is 10.30%.

At the current price of 39.42, it has a dividend yield of 4.18%, and its target price is 51.33. This is with a profit margin of *TBA, and total debt/equity of 0.32. Sanofi (NYSE:SNY) has a P/E of 22, as well as a forward P/E of 13.03.

With a current EPS of 1.8, and a forecasted EPS growth for next year at -1.62%,Sanofi (NYSE:SNY) has had a EPS growth for the past five years at -4.40%. For the next five years EPS growth is projected to be 6.40%.

Performance for the year is -18.50%. Since its IPO date on 7/1/2002, the total performance to date is -3.07%.

Volume today for Sanofi (NYSE:SNY), is 1741286, while its average volume is 2201.83. Whilst the total gain today was -0.62%, it did have a day high of -7.78%.

Volatility for this week has been at 0.99%, and 1.11% for the month. The 52-week low for Sanofi, SNY has been 9.18%, while the 52-week-high has reached -20.81%.

Looking at its return of investments, which is 6.50%, and its return on assets is *TBA. Sanofi (NYSE:SNY) has an operating margin of *TBA. With a sales growth of -54.00% quarter over quarter. Bearing in mind that Sanofi, SNY is in the sector Healthcare, its long-term debt/equity is 0.27, and has a current ratio of 1.5 and 1 for quick ratio.

So what is the value of Sanofi? Well its PEG is 3.44, and the P/S is 2.64, along with a P/B of 1.66. Meanwhile it has a p/cash of 14.49.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment